Celldex Therapeutics, Inc. (CLDX)
31.10
-0.38
(-1.21%)
USD |
NASDAQ |
Sep 25, 16:00
31.10
0.00 (0.00%)
After-Hours: 17:50
Celldex Therapeutics Price : 31.10 for Sept. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | 31.48 | 31.66 | 30.59 | 31.48 | 2.298M |
| Sep 23, 2026 | 33.54 | 33.59 | 30.40 | 31.12 | 4.236M |
| Sep 22, 2026 | 36.60 | 38.39 | 30.39 | 33.51 | 12.89M |
| Sep 21, 2026 | 41.62 | 41.62 | 37.48 | 37.89 | 549513.0 |
| Sep 18, 2026 | 38.87 | 38.87 | 37.54 | 38.24 | 2.082M |
| Sep 17, 2026 | 39.47 | 40.66 | 38.92 | 38.98 | 1.279M |
| Sep 16, 2026 | 38.59 | 39.21 | 38.25 | 38.71 | 1.001M |
| Sep 15, 2026 | 39.00 | 39.19 | 37.74 | 38.51 | 686390.0 |
| Sep 14, 2026 | 37.40 | 39.42 | 37.27 | 39.18 | 1.000M |
| Sep 11, 2026 | 38.39 | 38.59 | 36.84 | 36.90 | 1.034M |
| Sep 10, 2026 | 38.78 | 38.86 | 37.75 | 38.10 | 949012.0 |
| Sep 09, 2026 | 38.95 | 40.04 | 38.67 | 38.78 | 588416.0 |
| Sep 08, 2026 | 38.78 | 39.86 | 38.50 | 39.12 | 834306.0 |
| Sep 04, 2026 | 38.96 | 39.81 | 38.90 | 39.68 | 414532.0 |
| Sep 03, 2026 | 39.50 | 39.88 | 38.95 | 39.37 | 417999.0 |
| Sep 02, 2026 | 39.43 | 40.55 | 39.01 | 39.48 | 476586.0 |
| Sep 01, 2026 | 39.13 | 39.90 | 38.94 | 39.24 | 542484.0 |
| Aug 31, 2026 | 38.86 | 39.84 | 38.74 | 39.63 | 696907.0 |
| Aug 28, 2026 | 40.33 | 40.57 | 39.04 | 39.12 | 424938.0 |
| Aug 27, 2026 | 40.44 | 41.00 | 40.02 | 40.46 | 450009.0 |
| Aug 26, 2026 | 41.18 | 42.12 | 40.06 | 40.57 | 540669.0 |
| Aug 25, 2026 | 41.02 | 41.92 | 40.63 | 41.22 | 550919.0 |
| Aug 24, 2026 | 40.16 | 40.98 | 39.53 | 40.57 | 416889.0 |
| Aug 21, 2026 | 40.38 | 41.24 | 40.12 | 40.38 | 837685.0 |
| Aug 20, 2026 | 41.40 | 42.00 | 39.45 | 39.94 | 1.003M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Gilead Sciences, Inc. | 150.90 |
| ACADIA Pharmaceuticals, Inc. | 20.68 |
| Alnylam Pharmaceuticals, Inc. | 256.06 |
| Anika Therapeutics, Inc. | 20.41 |
| Savara, Inc. | 5.005 |
Price Related Metrics
| PS Ratio | 13646.36 |
| PEG Ratio | -0.1589 |
| Price to Book Value | 3.417 |
| Earnings Yield | -14.02% |
| Market Cap | 2.441B |
| PEGY Ratio | -0.1589 |